NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

IQV

IQVIA Holdings Inc

Apr 22 • 02:05PM ET

142.07

Dollar change +0.85
Percentage change 0.60	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: CROX MEDP LH ICON CTLT CRL INCY

| Held by: VTI VOO VO SPY IVV VTV VOT XLV IBB COWZ

Scroll to Statements

Index	S&P 500	P/E	18.95	EPS (ttm)	7.50	Insider Own	0.87%	Shs Outstand	176.10M	Perf Week	-5.87%
Market Cap	25.05B	Forward P/E	10.81	EPS next Y	13.14	Insider Trans	0.08%	Shs Float	174.79M	Perf Month	-23.58%
Income	1.37B	PEG	2.07	EPS next Q	2.63	Inst Own	94.19%	Short Float	1.80%	Perf Quarter	-30.93%
Sales	15.40B	P/S	1.63	EPS this Y	6.42%	Inst Trans	-1.14%	Short Ratio	1.78	Perf Half Y	-39.26%
Book/sh	34.45	P/B	4.12	EPS next Y	10.91%	ROA	5.13%	Short Interest	3.15M	Perf Year	-37.46%
Cash/sh	10.45	P/C	13.59	EPS next 5Y	9.15%	ROE	22.55%	52W Range	135.97 - 252.88	Perf YTD	-27.71%
Dividend Est.	-	P/FCF	11.85	EPS past 5Y	50.90%	ROI	7.12%	52W High	-43.82%	Beta	1.39
Dividend TTM	-	Quick Ratio	0.84	Sales past 5Y	7.04%	Gross Margin	27.66%	52W Low	4.48%	ATR (14)	7.57
Dividend Ex-Date	-	Current Ratio	0.84	EPS Y/Y TTM	2.46%	Oper. Margin	14.73%	RSI (14)	31.35	Volatility	3.30% 5.02%
Employees	88000	Debt/Eq	2.39	Sales Y/Y TTM	2.95%	Profit Margin	8.91%	Recom	1.48	Target Price	218.20
Option/Short	Yes / Yes	LT Debt/Eq	2.18	EPS Q/Q	-5.02%	Payout	0.00%	Rel Volume	0.66	Prev Close	141.22
Sales Surprise	0.78%	EPS Surprise	0.35%	Sales Q/Q	2.35%	Earnings	May 06 BMO	Avg Volume	1.77M	Price	142.07
SMA20	-10.69%	SMA50	-19.97%	SMA200	-32.20%	Trades		Volume	845,439	Change	0.60%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$170
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight	$250
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy	$285
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral	$248 → $202
Sep-06-23	Initiated	HSBC Securities	Buy	$260
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256
May-24-22	Initiated	Guggenheim	Buy	$244
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$231 → $255
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$235

Show Previous Ratings

Apr-21-25 04:15PM	IQVIA to Announce First-Quarter 2025 Results on May 6, 2025 (Business Wire)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
12:30AM	Cedar Creek Partners Q1 2025 Results (Seeking Alpha)
Apr-15-25 08:00AM	Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report (Business Wire)
Apr-11-25 12:30PM	Oakmark Global Select Fund Q1 2025 Commentary (Seeking Alpha)
12:20PM	Loading…
12:20PM	Oakmark Select Fund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 10:42AM	IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? (Zacks) -8.79%
Apr-08-25 09:43AM	IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love (Insider Monkey) -5.57%
Apr-01-25 02:27AM	Impax Global Social Leaders Fund Q4 2024 Commentary (Seeking Alpha)
Mar-31-25 03:15PM	Impax Large Cap Fund Q4 2024 Commentary (Seeking Alpha)
Mar-27-25 06:32PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Mar-26-25 10:59AM	Paychex Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y (Zacks)
10:53AM	Here's Why Investors Must Hold IQV Stock in Their Portfolios Now (Zacks)
05:03AM	Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Mar-24-25 12:35PM	Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
08:06PM	Loading…
Mar-23-25 08:06PM	Tracking William Nygren's Harris Associates Portfolio - Q4 2024 Update (SeekingAlpha)
Mar-21-25 07:40AM	IQVIA Holdings (IQV) Fell on Lowered Guidance (InsiderMonkey)
Mar-20-25 02:50AM	Lazard Global Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-19-25 05:09AM	3 Reasons IQV is Risky and 1 Stock to Buy Instead (StockStory)
Mar-10-25 09:00AM	IQVIA recognized as a leader in IDC MarketScapes 2024 assessment for decentralized clinical trial technologies and consulting services (Business Wire)
Mar-04-25 09:00AM	IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials (Business Wire)
Feb-25-25 09:40AM	IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Feb-24-25 09:00AM	IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence (Business Wire)
Feb-21-25 09:00AM	IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025 (Business Wire)
Feb-20-25 10:06AM	IQVIA Releases 2024 Sustainability Report (Business Wire)
Feb-14-25 09:15AM	IQVIA (IQV) International Revenue Performance Explored (Zacks)
Feb-12-25 08:03AM	West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-07-25 03:36PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
02:15AM	IQVIA Holdings Inc (IQV) Q4 2024 Earnings Call Highlights: Record Free Cash Flow and Strategic ... (GuruFocus.com)
02:08AM	Q4 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Loading…
Feb-06-25 09:30AM	Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings (Zacks)
08:10AM	IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates (Zacks)
08:08AM	IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars (StockStory)
07:17AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance (Business Wire)
Feb-05-25 08:10AM	IQVIA (IQV) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-04-25 11:00AM	IQVIA named to the Fortune Worlds Most Admired Companies list, ranked No. 1 in its sector for fourth consecutive year (Business Wire)
09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
Feb-03-25 09:50AM	IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:16AM	Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jan-30-25 03:55AM	IQVIA Holdings Inc. (IQV): Driving Healthcare Advancements with NVIDIA AI Collaboration (Insider Monkey)
Jan-21-25 04:15PM	IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025 (Business Wire)
Jan-17-25 09:50AM	Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock (Zacks)
Jan-16-25 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
Jan-15-25 12:10PM	Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:34AM	IQVIA Holdings (IQV) Fell Due to Reduced Near-Term Outlook in its R&D Solutions (Insider Monkey)
Jan-13-25 02:12PM	Why Tech Stocks Are Dropping Monday (Investopedia)
09:00AM	JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic (Pharmaceutical Technology)
09:00AM	IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions (Business Wire)
Dec-23-24 10:19AM	IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains? (Zacks)
08:00AM	Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute (Business Wire)
Dec-14-24 09:00PM	The Drugs Young Bankers Use to Get Through the Dayand Night (The Wall Street Journal)
Dec-04-24 10:55AM	A 12-Year-Olds Journey Into the World of Ozempic (The Wall Street Journal)
Dec-03-24 12:41AM	Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China (The Wall Street Journal)
Nov-06-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 (Business Wire)
Nov-05-24 07:11AM	Iqvia price target lowered to $265 from $280 at Morgan Stanley (TipRanks)
Nov-04-24 09:15AM	Interpreting IQVIA (IQV) International Revenue Trends (Zacks)
Nov-01-24 02:27PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
03:10AM	IQVIA Holdings Inc (IQV) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges (GuruFocus.com)
01:04AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
12:45AM	Q3 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-31-24 08:30PM	IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:13AM	IQVIA: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day (Business Wire)
Oct-30-24 09:42AM	IQVIA Holdings Inc. (IQV): Among UBS Top Tech Based Disruptive Stocks For 2030 (Insider Monkey)
Oct-28-24 09:16AM	Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Oct-24-24 10:01AM	IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -7.27%
Oct-15-24 04:15PM	IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 (Business Wire)
Oct-04-24 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
Oct-02-24 09:00AM	IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI (Business Wire)
Sep-25-24 06:20PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
08:26AM	IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock Right Now (Insider Monkey)
Sep-19-24 09:00AM	IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award (Business Wire)
Sep-17-24 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
01:12AM	IQVIA Holdings Inc. (NYSE:IQV): A Non-Tech Stock With Long-Term Investment Potential (Insider Monkey)
Sep-13-24 01:41PM	Goldman Thinks IQVIA Holdings Inc. (IQV) Is A Long-Term AI Stock Set To Rally Eventually (Insider Monkey)
Sep-12-24 09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-04-24 02:23PM	Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst (Benzinga)
09:00AM	Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative (PR Newswire)
Aug-29-24 06:24PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Aug-21-24 04:15PM	IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024 (Business Wire)
11:30AM	IQVIA (IQV) Up 3.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-16-24 10:09AM	Here's Why You Should Retain IQVIA (IQV) Stock for Now (Zacks)
Aug-14-24 09:45AM	How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates (GlobeNewswire)
Jul-31-24 04:13PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-29-24 09:15AM	Understanding IQVIA (IQV) Reliance on International Revenue (Zacks)
Jul-25-24 06:18PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-24-24 03:26AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Jul-23-24 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
01:49AM	Q2 2024 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
01:00AM	Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight (GuruFocus.com)
Jul-22-24 06:30PM	Compared to Estimates, IQVIA (IQV) Q2 Earnings: A Look at Key Metrics (Zacks) +9.20%
04:28PM	Iqvia Bolts Higher After A Surprise Segment Beat Saved Its Second Quarter (Investor's Business Daily)
01:47PM	IQVIA Stock Pops After It Beats Q2 Earnings Estimates (Investopedia)
11:25AM	IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q2 (Zacks)
10:37AM	IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings (Benzinga)
08:15AM	IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:11AM	IQVIA: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Second-Quarter 2024 Results (Business Wire)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOUSBIB ARI	See Remarks	Feb 10 '25	Option Exercise	65.16	40,000	2,606,400	837,083	Feb 12 05:11 PM
DANHAKL JOHN G	Director	Dec 03 '24	Buy	200.58	1,275	255,740	1,275	Feb 07 07:03 PM
Sherbet Eric	See Remarks	Aug 27 '24	Sale	246.33	1,300	320,229	19,536	Aug 29 05:02 PM
Sherbet Eric	Officer	Aug 27 '24	Proposed Sale	246.33	1,300	320,229		Aug 27 05:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your FINVIZ experience